After helming specialty pharmaceutical company Clinigen for the past 6 years, Peter George is stepping aside as chief executive to make room for Shaun Chilton…

Actinium Pharmaceuticals has partnered up with Memphis, TN-based CRO Vector Oncology to help it with a midstage study of its experimental blood cancer med…

Building on their 5-year, 2012 endometriosis research deal, and clearly happy with what it has seen, German pharma Bayer has notched another pact with Evotec,…

Medical testing company LabCorp, after buying up NJ-headquartered CRO Covance in a deal worth just over $6 billion last year, has now decided on a full-time…

Lonza Houston and Massachusetts Eye and Ear, the world’s largest vision and hearing research center, have inked a new pact that will allow gene therapy players…

After days of rumors that Dr. Ron Farkas, a vocal FDA critic of Sarepta’s Duchenne med eteplirsen, had left the agency, Parexel has confirmed to FierceCRO that…

Apparent Lonza target Catalent has produced an about-face with its buyout of drug development and clinical manufacturing co Pharmatek for an undisclosed sum.

Japanese pharma Takeda has announced a major shake-up of its clinical and drug development as it looks to move hundreds of its staff over to PRA Health with…